使用微电极分析三维胃肠道类器官中的管腔 pH 值
July 5th, 2024
1.4K views
本方案描述了使用微电极在人体组织来源的胃类器官中进行 pH 值测量，用于腔内生理学的时空表征。
我们研究的总体目标是了解胃上皮细胞、免疫细胞、基质细胞及其产物（如细胞因子和粘液）如何协同工作以应对胃病原体幽门螺杆菌感染。为此，我们正在尝试构建人类胃粘膜的复杂生理相关模型。先前对胃类器官的研究显示，关于这些模型维持分泌酸的壁细胞的能力，结果相互矛盾。
使用 pH 微电极，我们证明在没有特异性分化或刺激方案的情况下，人胃类器官在管腔中保持接近中性的 pH 值。相对而言，类器官腔长期以来一直限制我们对内部微环境的理解。我们展示了首次成功的微电极 pH 测量，用于类器官的功能表征。
我们基于微电极的方法可以为研究人员提供一种可靠的工具，以适应他们的特定需求。到目前为止，胃肠道类器官内的 pH 值测量涉及使用 pH 敏感染料，这些染料依赖于显微镜成像进行定量。使用微电极的主要优点是它们提供准确的数值 pH 读数。
此外，可以实时记录腔内 pH 值，并具有卓越的空间分辨率。我们正在努力开发具有生理 pH 梯度的人类胃粘液层的全功能模型，以便我们可以研究该屏障在幽门螺杆菌感染中的作用。最终目标是开发新的细胞保护疗法，以增强粘液层并防止细菌入侵。
概览
本协议概述了使用微电极在人源胃类器官中进行pH测量的方法，使得能够对腔内生理学进行时空表征。该研究旨在增强对幽门螺杆菌感染引起的胃上皮反应的理解。
关键研究组成部分
科学领域
- 神经科学
- 胃肠病学
- 细胞生物学
背景
- 胃类器官被用于模拟人体胃黏膜。
- 先前的研究显示关于酸分泌壁细胞的结果存在矛盾。
- 理解类器官内的微环境对于研究胃生理学至关重要。
- 微电极为准确的pH测量提供了一种新方法。
研究目的
- 开发一种可靠的方法来测量胃类器官中的腔内pH。
- 研究胃粘液层在幽门螺杆菌感染中的作用。
- 创建一个可以引导新的细胞保护治疗的模型。
使用的方法
- 人源胃类器官的制备。
- 使用微电极进行实时pH测量。
- 微电极的校准以获得准确读数。
- 记录类器官不同区域的pH。
主要结果
- 在缺乏特定协议的情况下，人源胃类器官维持近中性pH。
- 微电极允许精确的pH读数和空间分辨率。
- 在多个类器官中观察到腔内pH的变化。
- 该方法可以适应各种研究需求。
结论
- 基于微电极的方法对于研究胃类器官生理学是有效的。
- 理解pH动态可以为胃感染的治疗策略提供信息。
- 这种方法增强了开发新的治疗干预措施的潜力。
常见问题
什么是胃类器官？
胃类器官是模拟人体胃黏膜结构和功能的3D细胞培养系统。
微电极如何改善pH测量？
微电极提供准确的数值pH读数，并允许具有优越空间分辨率的实时监测。
研究胃类器官中的pH有何重要性？
研究pH有助于理解胃细胞的微环境和生理反应，特别是在感染期间。
这种方法可以适应其他类型的类器官吗？
是的，微电极方法可以根据各种类器官模型和研究需求进行调整。
这项研究的潜在应用是什么？
研究结果可能导致新的胃感染治疗方法，并增强我们对胃生理学的理解。
Executive Industry Relevance
Quantitative profiling of luminal pH in 3D gastrointestinal organoids using microelectrodes enables precise functional characterization of disease-relevant tissue models. This capability supports predictive confidence in early discovery and target validation for gastric mucosal biology, particularly in infection and barrier function studies. Reliable intraluminal measurements facilitate translational continuity from discovery through preclinical model development in biopharma R&D portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of epithelial and barrier function hypotheses in physiologically relevant organoid systems.
- Supports biological de-risking by providing direct, quantitative readouts of luminal microenvironment changes.
- Facilitates functional target validation for pathways involved in gastric infection and mucosal defense.
Screening & Assay Development
- Prepares validated organoid models for downstream compound screening and mechanistic studies.
- Delivers standardized, reproducible, and quantitative pH outputs for assay development.
- Enables high-resolution, real-time monitoring of luminal conditions to support reliable compound evaluation.
Translational & Preclinical Research
- Aligns organoid model outputs with disease-relevant physiological parameters for translational biomarker development.
- Provides continuity from in vitro discovery to preclinical validation of gastric barrier function and infection models.
- Supports risk-adjusted advancement decisions by clarifying mechanistic underpinnings of candidate interventions.
Pipeline & Workflow Integration
This microelectrode-based pH profiling method integrates into the discovery-to-preclinical continuum, bridging early hypothesis testing with translational model validation.
- Discovery Biology: Enables hypothesis testing and pathway clarification in complex organoid systems.
- Screening: Provides reproducible, quantitative pH measurements for assay readiness and standardization.
- Analytics: Delivers high-resolution, real-time readouts to compare experimental conditions and model outputs.
- Translational Research: Connects in vitro findings to preclinical models by aligning with physiological pH gradients and barrier function.
- Enterprise Reuse: Establishes a reusable platform for functional characterization across diverse organoid-based studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in gastric mucosal research.
- Operational Value: Standardizes luminal pH measurement with scalable, reproducible instrumentation.
- Strategic Value: Improves go/no-go decisions and capital efficiency by clarifying functional model outputs.
- Portfolio Impact: Enables risk-adjusted prioritization of discovery and preclinical programs targeting gastric barrier and infection pathways.
Implementation Considerations
- Requires expertise in organoid culture and micromanipulator-controlled microelectrode operation.
- Needs access to calibrated microelectrodes, reference electrodes, and compatible analytical software.
- Demands cross-team standardization of measurement protocols for reproducibility.
- Adaptation may be necessary for different organoid types or luminal environments.
- Spatial resolution and measurement duration are limited by organoid size and electrode stability.
Biopharma FAQs
Why does null hypothesis testing matter for microelectrode pH profiling?
Null hypothesis testing ensures that observed pH differences in organoid lumina are statistically significant and not due to random variation. This rigor is essential for validating functional hypotheses about gastric barrier or infection mechanisms in early discovery. Reliable statistical analysis underpins confidence in target validation decisions.
How does independent variable isolation fit in organoid pH measurement?
Isolating variables such as media composition or organoid line enables precise attribution of pH changes to specific experimental factors. This approach supports mechanistic de-risking and clarifies the impact of interventions within the discovery pipeline. Controlled variable testing strengthens the predictive value of organoid models.
What do quantitative dependent variable measurements enable in this protocol?
Quantitative pH readings provide objective, reproducible outputs for comparing organoid conditions and assessing functional responses. These measurements support assay development, screening readiness, and translational biomarker alignment. High-resolution data facilitate robust cross-study and cross-team analyses.
Why are replication requirements critical for cross-functional collaboration?
Replicating pH measurements across multiple organoids and lines ensures data reliability and reproducibility for collaborative R&D teams. Consistent outputs enable integration of findings into broader discovery and preclinical workflows. Standardized replication supports enterprise-wide adoption of organoid-based assays.
What statistical analysis capabilities are required before implementing microelectrode pH assays?
Robust statistical tools are needed to analyze pH variability, assess significance, and compare conditions across organoid lines. These capabilities ensure that measurement outputs inform actionable R&D decisions and support risk-adjusted advancement in the discovery pipeline.
